Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 7 minutes ago
Back to Filings
FORM 4
AI

Insider Trading - August 29, 2025

Filed August 29, 2025
·
Period ending August 27, 2025
·
0002001011-25-000066

Director Saintil granted 3,960 RSUs (value $0) as compensation.

Brief

Merline Saintil, a Director at Rocket Lab USA Inc., was granted 3,960 restricted stock units (RSUs) of common stock on August 27, 2025, at $0.00 per share. This is standard non-employee director compensation under the company's policy. The signal is neutral, as it represents routine equity grants rather than discretionary buying or selling.

Detailed Brief

On August 27, 2025, Merline Saintil, a Director of Rocket Lab USA Inc. (RKLB), received a grant of 3,960 RSUs in common stock priced at $0.00 per share, as reported in the Form 4 filed on August 29, 2025. Following the transaction, Saintil beneficially owns 423,529 shares directly. These RSUs were awarded pursuant to the Rocket Lab Corporation Amended and Restated Non-Employee Director Compensation Policy and the 2021 Stock Option and Incentive Plan, vesting in full on the earlier of the next Annual Meeting of Stockholders or the one-year anniversary of the grant date, subject to continued board service. No 10b5-1 plan is indicated, and there are no derivative transactions in Table II. This appears to be a standard quarterly or annual director compensation grant with no unusual pattern or context provided relative to prior filings, earnings, or market events.

Key Telemetry

  • Transaction adds 3,960 shares (~0.9% of post-transaction direct holdings of 423,529 shares).
  • Routine RSU grant for non-employee director compensation; vests in ~1 year.
  • Occurred at $0.00 (grant value); no market price impact.
  • No prior pattern context available; neutral timing pre-next earnings.

Impact Vector

This routine RSU grant to a director signals neutral insider confidence, as it is standard compensation rather than a voluntary purchase or sale indicating personal conviction about the stock's prospects.

Search
Search across missions, customers, news, and SEC filings